U.S. pharma big copyright scrapped two experimental weight loss supplements past yr—a at the time-day by day tablet, lotiglipron, because of elevated liver enzymes in addition to a 2 times-daily tablet, danuglipron, as a result of powerful Unintended effects—but CEO Albert Bourla has